Cargando…

Association between glycemic control and cardiovascular events in older Japanese adults with diabetes mellitus: An analysis of the Japanese medical administrative database

AIMS/INTRODUCTION: The relationship between glycated hemoglobin (HbA1c) and cardiovascular events in older adults was investigated using a Japanese administrative medical database. MATERIALS AND METHODS: Anonymized medical data on patients with diabetes mellitus aged ≥65 years for the period from Ja...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yokote, Koutaro, Suzuki, Ryo, Gouda, Maki, Iijima, Hiroaki, Yamazaki, Akiko, Inagaki, Masaya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8565425/ https://www.ncbi.nlm.nih.gov/pubmed/33988907 http://dx.doi.org/10.1111/jdi.13575

Ejemplares similares

Associations between eating habits and glycemic control and obesity in Japanese workers with type 2 diabetes mellitus
por: Gouda, Maki, et al.
Publicado: (2018)

Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
por: Iijima, Hiroaki, et al.
Publicado: (2015)

Effects of Baseline Blood Pressure and Low-Density Lipoprotein Cholesterol on Safety and Efficacy of Canagliflozin in Japanese Patients with Type 2 Diabetes Mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2015)

Efficacy and safety of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes mellitus: Results of a 24‐week, randomized, double‐blind, placebo‐controlled trial
por: Kadowaki, Takashi, et al.
Publicado: (2017)

Efficacy and safety of teneligliptin added to canagliflozin monotherapy in Japanese patients with type 2 diabetes mellitus: A multicentre, randomized, double‐blind, placebo‐controlled, parallel‐group comparative study
por: Kadowaki, Takashi, et al.
Publicado: (2017)

Epidemiology of sepsis in a Japanese administrative database
por: Imaeda, Taro, et al.
Publicado: (2023)

Long‐term safety and efficacy of canagliflozin as add‐on therapy to teneligliptin in Japanese patients with type 2 diabetes
por: Kadowaki, Takashi, et al.
Publicado: (2017)

Efficacy and safety of canagliflozin in combination with insulin: a double-blind, randomized, placebo-controlled study in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2016)

Multidrug use positively correlates with high-risk prescriptions in the Japanese elderly: a longitudinal study
por: Arai, Sayaka, et al.
Publicado: (2019)

Pharmacokinetics and exploratory efficacy biomarkers of bococizumab, an anti-PCSK9 monoclonal antibody, in hypercholesterolemic Japanese subjects
por: Yokote, Koutaro, et al.
Publicado: (2019)

Ceritinib‐associated hyperglycemia in the Japanese Adverse Drug Event Report Database
por: Fujita, Haruka, et al.
Publicado: (2019)

Dose‐dependent reduction in body weight with LIK066 (licogliflozin) treatment in Japanese patients with obesity
por: Yokote, Koutaro, et al.
Publicado: (2020)

The risk of antibiotics and enterocolitis for the development of inflammatory bowel disease: a Japanese administrative database analysis
por: Shimodaira, Yosuke, et al.
Publicado: (2022)

Long‐term efficacy and safety of canagliflozin in combination with insulin in Japanese patients with type 2 diabetes mellitus
por: Inagaki, Nobuya, et al.
Publicado: (2017)

Impact of the 8-week Administration of Tofogliflozin for Glycemic Control and Body Composition in Japanese Patients with Type 2 Diabetes Mellitus
por: Hirose, Sachie, et al.
Publicado: (2016)

N-3 polyunsaturated fatty acids improve lipoprotein particle size and concentration in Japanese patients with type 2 diabetes and hypertriglyceridemia: a pilot study
por: Ide, Kana, et al.
Publicado: (2018)

Effect of sodium–glucose cotransporter 2 inhibitor medication on new prescriptions of antihypertensives, antigout/antihyperuricemics and antidyslipidemics in Japan: Analysis using the JMDC Claims Database
por: Gouda, Maki, et al.
Publicado: (2022)

Analysis of polypharmacy effects in older patients using Japanese Adverse Drug Event Report database
por: Abe, Junko, et al.
Publicado: (2017)

Effect of antipsychotics on breast tumors by analysis of the Japanese Adverse Drug Event Report database and cell-based experiments
por: Maeshima, Tae, et al.
Publicado: (2021)

Effect of Canagliflozin on Urinary Albumin Excretion in Japanese Patients with Type 2 Diabetes Mellitus and Microalbuminuria: A Pilot Study
por: Osonoi, Takeshi, et al.
Publicado: (2018)

Validity of Claims Diagnosis Codes for Cardiovascular Diseases in Diabetes Patients in Japanese Administrative Database
por: Ono, Yasuhisa, et al.
Publicado: (2020)

Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
por: Inoue, Misaki, et al.
Publicado: (2021)

Association between eating behavior and poor glycemic control in Japanese adults
por: Iwasaki, Takahiro, et al.
Publicado: (2019)

Intussusception among Japanese children: an epidemiologic study using an administrative database
por: Takeuchi, Masato, et al.
Publicado: (2012)

Drug Utilization of Japanese Patients Diagnosed with Schizophrenia: An Administrative Database Analysis
por: Cheung, Stephane, et al.
Publicado: (2017)

Association of the Glycemic Fluctuation as well as Glycemic Control with the Pancreatic β-cell Function in Japanese Subjects with Type 2 Diabetes Mellitus
por: Takai, Maiko, et al.
Publicado: (2018)

Effect of Tofogliflozin on Body Composition and Glycemic Control in Japanese Subjects with Type 2 Diabetes Mellitus
por: Kamei, Shinji, et al.
Publicado: (2018)

Analysis of Drug-Induced Gastrointestinal Obstruction and Perforation Using the Japanese Adverse Drug Event Report Database
por: Satake, Riko, et al.
Publicado: (2021)

Impact of gender differences on lifestyle and glycemic control in Japanese patients with diabetes during COVID-19 lockdowns
por: Shikuma, Jumpei, et al.
Publicado: (2022)

Analysis of anticholinergic adverse effects using two large databases: The US Food and Drug Administration Adverse Event Reporting System database and the Japanese Adverse Drug Event Report database
por: Nagai, Junko, et al.
Publicado: (2021)

Author Correction: Analysis of chemotherapy-induced peripheral neuropathy using the Japanese Adverse Drug Event Report database
por: Inoue, Misaki, et al.
Publicado: (2022)

Validation of novel identification algorithms for major adverse cardiovascular events in a Japanese claims database
por: Shima, Daisuke, et al.
Publicado: (2020)

Imeglimin‐mediated glycemic control in maternally inherited deafness and diabetes
por: Ishibashi, Ryoichi, et al.
Publicado: (2023)

A Japanese boy with NAA10-related syndrome and hypertrophic cardiomyopathy
por: Shishido, Ayumi, et al.
Publicado: (2020)

Ceritinib Aggravates Glycemic Control in Insulin-treated Patients with Diabetes and Metastatic ALK-positive Lung Cancer
por: Sakuma, Ikki, et al.
Publicado: (2018)

Analysis of drug-induced interstitial lung disease using the Japanese Adverse Drug Event Report database
por: Matsumoto, Kiyoka, et al.
Publicado: (2020)

Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis using the Japanese Adverse Drug Event Report database
por: Abe, Junko, et al.
Publicado: (2016)

Adverse event profiles of microscopic colitis in the Japanese Adverse Drug Event Report (JADER) database
por: Yamashiro, Kaito, et al.
Publicado: (2022)

Utility of indices using C‐peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes
por: Funakoshi, Shogo, et al.
Publicado: (2011)

Continuous glucose monitoring reveals hypoglycemia risk in elderly patients with type 2 diabetes mellitus
por: Ishikawa, Takahiro, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rshnmsjj4hkb52cr81f1gv550d